Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Recombinant Human Erythropoietin Alfa (4000IU) Injection
Therapeutic Category
Nephrology
Dosage Form
Injection
Packaging Type
Pre-Filled Syringe
Packaging
1ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Recobent 4k Injection contains Recombinant Human Erythropoietin Alfa 4000 IU, a clinically proven erythropoiesis-stimulating agent used to treat anemia related to chronic kidney disease, chemotherapy, and other conditions involving reduced red blood cell production.
Recombinant Human Erythropoietin Alfa acts on bone marrow to stimulate red blood cell synthesis, helping improve hemoglobin levels and reduce the need for blood transfusions. This makes it an essential therapy in long-term anemia management.
The 4000 IU strength offers balanced dosing flexibility for both initiation and maintenance therapy. Its predictable response profile and acceptance in hospital and specialty care settings ensure steady demand.
Adding Recobent 4k Injection to your injectable and anemia care portfolio strengthens your range with a high-value, institution-driven product. Its strong prescriber trust, consistent usage, and export suitability make it an ideal choice for PCD pharma companies, distributors, and third-party manufacturing partners.
Common side effects may include headache, increased blood pressure, fever, nausea, joint pain, or injection-site reactions. Rare but serious side effects include thromboembolic events or allergic reactions. Immediate medical attention is advised if severe or unusual symptoms occur.
Recobent 4K Injection is indicated for the treatment of anemia associated with chronic kidney disease, chemotherapy-induced anemia in cancer patients, anemia related to zidovudine therapy in HIV patients, and anemia due to certain chronic medical conditions, as prescribed by a healthcare professional.
Recobent 4K Injection should be administered only under medical supervision. Regular monitoring of hemoglobin levels and blood pressure is essential during therapy. Dosage and treatment duration must be decided by the treating physician.
Store Recobent 4K Injection at 2°C–8°C in a refrigerator. Do not freeze. Protect from light. Keep out of reach of children and do not use if the solution is cloudy or discolored.
Composition : Iron & calcium tonic
Composition : Iron Sucrose 20mg Injection
Composition : Elemental Iron 10mg + Folic Acid 200mcg + Vitamin B12 100mcg
Composition : Elemental Iron 100mg/5ml
Composition : Sodium Feredetate 231mg (Eq. to Elemental Iron 33mg) + Folic Acid 5mg + Vitamin B12 15mcg + Zinc Sulphate Monohydrate 5mg
Composition : Ferrous Bisglycinate 100 mg + Folic Acid 200 mcg (RDA 20%) + Vitamin B12 (Cyanocobalamin) 1 mcg (RDA 100%) + Zinc Sulphate 22.5 mg (RDA 68%) + Sorbitol base q.s. Syrup
Composition : Ferrous Bisglycinate (60mg) + Zinc bisglycinate (15mg) + Folic Acid (1mg) + Methylcobalamin (500mcg)
Composition : Ferrous Ascorbate (100mg) + Folic Acid (1.5mg) + Zinc (22.5mg)
Composition : Ferrous Fumarate 19mg + Zinc Sulphate 12mg + Folic Acid 140mcg
Composition : Ferrous Ascorbate 100mg + Folic Acid 1.5mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This injection has strong demand in the nephrology and anemia management segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on hospital, dialysis, and critical-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of anemia associated with chronic kidney disease (CKD), dialysis patients, cancer-related anemia, and post-chemotherapy anemia (under specialist supervision). Recombinant Human Erythropoietin Alfa 4000 IU stimulates red blood cell production in bone marrow Widely used in nephrology, dialysis centers, and hospital-based care settings This strengthens a reliable hospital injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Erythropoietin Alfa Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong dialysis center demand, hospital institutional supply, specialist prescriptions, long-term therapy usage, reliable supply chain support, and good margins in nephrology injectables.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.